ReviewEFORT open reviews2023
Current indications for denosumab in benign bone tumours.
Antal Imre et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ReviewEFORT open reviews2023
Antal Imre et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.